Agriculture Leads DuPont to Solid Second Quarter Growth

* Reuters is not responsible for the content in this press release.

Tue Jul 22, 2008 6:00am EDT

Company Increases Lower End of 2008 Earnings Outlook Range
    WILMINGTON, Del., July 22 /PRNewswire-FirstCall/ --

    Highlights

    -- Second quarter 2008 earnings per share grew 13 percent to $1.18, up
from $1.04 in the second quarter of 2007.  Earnings benefited $.07 per share
from a litigation settlement and a lower base tax rate.
    -- Sales increased 12 percent to $8.8 billion, reflecting 7 percent higher
local selling prices, 5 percent currency benefit, 1 percent higher volumes and
a 1 percent reduction from portfolio changes.  Sales outside the United States
grew 18 percent, while sales in the United States grew 5 percent despite
weakness in housing and automotive markets.
    -- Local selling prices increased 7 percent, partially offsetting a 15
percent increase in energy, raw materials and freight costs in the second
quarter.
    -- Agriculture & Nutrition sales grew 23 percent, reflecting strong global
demand for the company's corn, soybean and crop protection products.
    -- Fixed costs as a percentage of sales improved 200 basis points from the
prior-year quarter, reflecting the company's continued cost productivity
improvement programs.
    -- DuPont (NYSE: DD) increased the lower end of its full year 2008
earnings outlook, narrowing the range to $3.45 to $3.55 per share.
    "DuPont captured strong growth in agriculture and emerging markets and
grew earnings despite accelerating raw material and energy costs in the second
quarter.  We are executing well in a challenging environment," said DuPont
Chairman and CEO Charles O. Holliday, Jr.  "DuPont's strategic transformation
in recent years is enabling us to successfully adapt to the new reality of
significantly higher commodity costs and we remain focused on achieving our
2010 accelerated growth plan."
    Global Consolidated Sales and Net Income
    Consolidated net sales grew 12 percent to $8.8 billion.  Sales outside the
United States grew 18 percent and accounted for 60 percent of worldwide sales.
Sales in emerging markets grew 23 percent.  A summary of second quarter 2008
worldwide and regional sales performance is shown in the table below.

                         Three Months Ended
                           June 30, 2008         Percentage Change Due to:
                                           Local
                                      %   Currency Currency
    (dollars in billions)     $    Change  Price    Effect   Volume Portfolio
    U.S.                     $3.5      5       9        -        (4)     -
    Europe                    2.7     18       4       12         3     (1)
    Asia Pacific              1.5     18       5        4        11     (2)
    Canada & Latin America    1.1     17       6        7         5     (1)

    Total Consolidated Sales $8.8     12       7        5         1     (1)


    Net income for the second quarter of 2008 was $1,078 million, or $1.18 per
share.  Second quarter 2007 net income was $972 million, or $1.04 per share.
    Earnings Per Share
    The table below shows the variances in second quarter 2008 earnings per
share (EPS) versus second quarter 2007.  The 13 percent increase in earnings
per share reflects higher local prices, favorable currency impact, and volume
growth outside the United States.  These gains were partially offset by higher
ingredient costs and increased spending for growth initiatives and capacity
expansions.


                                   EPS Analysis
                                                          EPS

    2nd Quarter 2007                                     $1.04

    Variances:
         Local prices                                      .42
         Variable costs*                                  (.51)
         Volume                                            .03
         Fixed costs*                                     (.04)
         Currency                                          .11
         Pharmaceuticals                                   .02
         Tax rate**                                        .03
         Litigation settlement                             .04
         Fewer shares                                      .03
         Lower interest expense                            .01
    2nd Quarter 2008                                     $1.18

    *    Excludes volume and currency impact
    **   Includes $0.03 from a favorable tax settlement


    Business Segment Performance
    Segment sales and related variances versus the second quarter of 2007 are
shown in the table below:


    SEGMENT SALES*           Three Months Ended      Percentage Change
    (Dollars in billions)      June 30, 2008               Due to:

                                                   USD
                                  $   % Change    Price    Volume   Portfolio
    Agriculture & Nutrition      $2.5       23       15         9         (1)
    Coatings & Color
     Technologies                 1.9       10       11        (1)         -
    Electronic & Communication
     Technologies                 1.1       10        7         1          2
    Performance Materials         1.8        8       13        (5)         -
    Safety & Protection           1.6        8        9         2         (3)

    * Segment sales include transfers


    Segment pre-tax operating income (PTOI) was $1.7 billion, up 8 percent
versus the second quarter 2007, as shown below:

    PRE-TAX OPERATING INCOME
                                        Three Months Ended
                                           June 30, 2008
                                                               % Change vs.
     (Dollars in millions)             2008            2007         2007

    Agriculture & Nutrition            $504            $428            18
    Coatings & Color Technologies       247             226             9
    Electronic & Communication
     Technologies                       170             176            (3)
    Performance Materials               223             227            (2)
    Safety & Protection                 302             318            (5)
        Total Growth Platforms        1,446           1,375             5
    Pharmaceuticals                     265             241            10
    Other                                 1             (37)           nm
        Total Segments               $1,712          $1,579             8


    The following are business segment highlights comparing second quarter
2008 results to second quarter 2007.
    Agriculture & Nutrition
    -- Sales increased $467 million, or 23 percent, to $2.5 billion,
reflecting record seed revenue and strong global pricing actions across the
platform.
    -- PTOI increased 18 percent to $504 million, driven by higher volumes and
USD prices across all businesses, partially offset by growth investments,
higher commodity prices, and a $52 million charge on open soybean contracts.
    Coatings & Color Technologies
    -- Sales increased 10 percent to $1.9 billion.  Higher USD selling price
in all businesses and volume growth in emerging markets more than offset lower
volumes in North America.
    -- PTOI increased 9 percent to $247 million.  Sales growth and favorable
currency offset the impact of weak auto and housing markets and higher raw
material and transportation costs.
    Electronic & Communication Technologies
    -- Sales grew 10 percent to $1.1 billion, led by price gains and favorable
currency.  Strong demand for photovoltaics, printed packaging, and
refrigerants was partially offset by weakness in U.S. automotive electronics.
    -- PTOI was $170 million compared to $176 million in the prior-year
quarter, which included a $25 million pre-tax inventory valuation benefit.
Excluding this item, PTOI increased 13 percent, reflecting strong sales growth
and cost productivity gains.
    Performance Materials
    -- Sales grew 8 percent to $1.8 billion, driven by price gains, currency,
and strong growth in Asia Pacific.  Volumes outside Asia declined due to
weakness in automotive markets and the impact of scheduled production outages.
    -- PTOI decreased 2 percent to $223 million as significantly higher
ingredient costs and lower volumes offset the benefit of price increases.
    Safety & Protection
    -- Sales grew 8 percent to $1.6 billion.  Pricing gains, particularly in
chemicals, favorable currency and broad-based volume growth in emerging
markets was partially offset by lower volumes in the U.S. housing market.
    -- PTOI of $302 million was down 5 percent.  Significant earnings growth
in the chemical businesses was offset by less favorable product mix, lower
volumes in U.S. housing, higher raw material costs, and higher fixed costs
associated with growth investments.
    Additional information on segment performance is available on the DuPont
Investor Center website at www.dupont.com.
    Outlook
    The company increased the lower end of its full year 2008 earnings
outlook, narrowing the range to $3.45 to $3.55 per share.  The previous
earnings outlook was a range of $3.40 to $3.55.  First half 2008 earnings per
share increased significantly versus prior year, principally reflecting strong
growth in agriculture earnings, which are concentrated in the first half of
the year.  The company expects second half 2008 earnings per share to be
modestly lower than last year due to the impact of higher energy and
ingredient costs, lower demand in certain developed markets, lower income from
asset sales, and a higher base tax rate.  The company expects second half 2008
earnings per share to be about equally split between the third and fourth
quarters.
    "DuPont is executing extremely well in a tougher environment," Holliday
said.  "We remain focused on achieving the growth objectives of our 2010
Acceleration Plan."
    Use of Non-GAAP Measures
    Management believes that measures of income excluding significant items
("non-GAAP" information) are meaningful to investors because they provide
insight with respect to ongoing operating results of the company.  Such
measurements are not recognized in accordance with generally accepted
accounting principles (GAAP) and should not be viewed as an alternative to
GAAP measures of performance.  Reconciliations of non-GAAP measures to GAAP
are provided in Schedule D.
    DuPont is a science-based products and services company. Founded in 1802,
DuPont puts science to work by creating sustainable solutions essential to a
better, safer, healthier life for people everywhere.  Operating in more than
70 countries, DuPont offers a wide range of innovative products and services
for markets including agriculture and food; building and construction;
communications; and transportation.
    Forward-Looking Statements:  This news release contains forward-looking
statements based on management's current expectations, estimates and
projections.  All statements that address expectations or projections about
the future, including statements about the company's strategy for growth,
product development, market position, expected expenditures and financial
results are forward-looking statements.  Some of the forward-looking
statements may be identified by words like "expects," "anticipates," "plans,"
"intends," "projects," "indicates," and similar expressions.  These statements
are not guarantees of future performance and involve a number of risks,
uncertainties and assumptions.  Many factors, including those discussed more
fully elsewhere in this release and in documents filed with the Securities and
Exchange Commission by DuPont, particularly its latest annual report on Form
10-K and quarterly report on Form 10-Q, as well as others, could cause results
to differ materially from those stated.  These factors include, but are not
limited to changes in the laws, regulations, policies and economic conditions,
including inflation, interest and foreign currency exchange rates, of
countries in which the company does business; competitive pressures;
successful integration of structural changes, including restructuring plans,
acquisitions, divestitures and alliances; cost of raw materials, research and
development of new products, including regulatory approval and market
acceptance; seasonality of sales of agricultural products; and severe weather
events that cause business interruptions, including plant and power outages,
or disruptions in supplier and customer operations.


                     E. I. du Pont de Nemours and Company
                        Consolidated Income Statements
               (Dollars in millions, except per share amounts)


    SCHEDULE A
                                 Three Months Ended      Six Months Ended
                                     June  30,                 June 30,
                                 2008         2007         2008         2007
    Net sales                   $8,837       $7,875      $17,412      $15,720
    Other income, net              442          364          637          680
    Total                        9,279        8,239       18,049       16,400

    Cost of goods sold and
     other operating
     charges (a)                 6,426        5,602       12,382       11,196
    Selling, general and
     administrative
     expenses                      987          884        1,921        1,730
    Research and
     development expense           360          337          690          647
    Interest expense                94          108          174          207

    Total                        7,867        6,931       15,167       13,780

    Income before income
     taxes and minority
     interests                   1,412        1,308        2,882        2,620
    Provision for income
     taxes                         335          335          608          700
    Minority interests in
     (losses) earnings of
     consolidated
     subsidiaries                   (1)           1            5            3

    Net income                  $1,078         $972       $2,269       $1,917

    Basic earnings per
     share of common stock       $1.19        $1.05        $2.51        $2.07

    Diluted earnings per
     share of common stock       $1.18        $1.04        $2.49        $2.05

    Dividends per share of
     common stock                $0.41        $0.37        $0.82        $0.74

    Average number of
     shares outstanding
     used in earnings per
     share (EPS)
     calculation:
      Basic                902,617,000  923,817,000  901,627,000  923,907,000
      Diluted              910,080,000  932,809,000  908,132,000  933,027,000


    (a) See Schedules of Significant Items for additional information.



                     E. I. du Pont de Nemours and Company
                         Consolidated Balance Sheets
               (Dollars in millions, except per share amounts)


    SCHEDULE A (continued)
                                                  June 30,        December 31,
                                                     2008             2007
    Assets
    Current assets
      Cash and cash equivalents                     $1,303            $1,305
      Marketable securities                            210               131
      Accounts and notes receivable, net             8,477             5,683
      Inventories                                    5,021             5,278
      Prepaid expenses                                 160               199
      Income taxes                                     565               564
        Total current assets                        15,736            13,160
    Property, plant and equipment, net of
     accumulated depreciation (June 30, 2008 -
     $16,425; December 31, 2007 - $15,733)          10,922            10,860
    Goodwill                                         2,085             2,074
    Other intangible assets                          2,796             2,856
    Investment in affiliates                           892               818
    Other assets                                     5,163             4,363
        Total                                      $37,594           $34,131

    Liabilities and Stockholders' Equity
    Current liabilities
      Accounts payable                              $2,846            $3,172
      Short-term borrowings and capital
       lease obligations                             4,432             1,370
      Income taxes                                     170               176
      Other accrued liabilities                      3,188             3,823
        Total current liabilities                   10,636             8,541
    Long-term borrowings and capital lease
     obligations                                     5,361             5,955
    Other liabilities                                7,287             7,255
    Deferred income taxes                              966               802
        Total liabilities                           24,250            22,553
    Minority interests                                 441               442

    Commitments and contingent liabilities

    Stockholders' equity
    Preferred stock                                    237               237
    Common stock, $0.30 par value;
     1,800,000,000 shares authorized; issued at
     June 30, 2008 - 989,194,000; December 31,
     2007 - 986,330,000                                297               296
    Additional paid-in capital                       8,336             8,179
    Reinvested earnings                             11,466             9,945
    Accumulated other comprehensive loss              (706)             (794)
    Common stock held in treasury, at cost
     (87,041,000 shares at June 30, 2008
     and December 31, 2007)                         (6,727)           (6,727)
        Total stockholders' equity                  12,903            11,136
          Total                                    $37,594           $34,131



                     E. I. du Pont de Nemours and Company
               Condensed Consolidated Statements of Cash Flows
                            (Dollars in millions)


    SCHEDULE A (continued)
                                                         Six Months Ended
                                                              June 30,
                                                       2008              2007

    Cash (used for) provided by operating activities  $(433)             $383

    Investing activities
      Purchases of property, plant and equipment       (892)             (621)
      Investments in affiliates                         (19)              (23)
      Payments for Businesses (Net of Cash Acquired)    (67)                -
      Other investing activities - net                 (356)              (28)
    Cash used for investing activities               (1,334)             (672)

    Financing activities
      Dividends paid to stockholders                   (749)             (692)
      Net increase in borrowings                      2,443               472
      Other financing activities - net                   46              (315)
    Cash provided by (used for) financing activities  1,740              (535)

    Effect of exchange rate changes on cash              25                (3)

    Decrease in cash and cash equivalents                (2)             (827)

    Cash and cash equivalents at beginning of period  1,305             1,814

    Cash and cash equivalents at end of period       $1,303              $987



                     E. I. du Pont de Nemours and Company
                        Schedules of Significant Items
               (Dollars in millions, except per share amounts)


    SCHEDULE B
    SIGNIFICANT ITEMS
                                            Pre-tax   After-tax ($ Per Share)
                                          2008  2007 2008  2007  2008    2007
    1st Quarter - Total (a)                 $-  $(52)  $-  $(52)   $-  $(0.06)

    2nd Quarter                             $-    $-   $-    $-    $-      $-

    2nd Quarter - Total                     $-    $-   $-    $-    $-      $-

    Year-to-date - Total                    $-  $(52)  $-  $(52)   $-  $(0.06)

    (a) First quarter 2007 includes a net $52 charge in Cost of goods sold and
other operating charges for litigation in the Performance Materials segment in
connection with the elastomers antitrust matter.
    See Schedule C for detail by segment.



                     E. I. du Pont de Nemours and Company
                       Consolidated Segment Information
                            (Dollars in millions)

    SCHEDULE C
                                       Three Months Ended   Six Months Ended
                                              June 30,          June 30,

    SEGMENT SALES (1)                       2008     2007      2008      2007
    Agriculture & Nutrition               $2,541   $2,074    $5,424    $4,524
    Coatings & Color Technologies          1,867    1,701     3,512     3,260
    Electronic & Communication
     Technologies                          1,074      979     2,100     1,899
    Performance Materials                  1,810    1,679     3,523     3,268
    Safety & Protection                    1,583    1,466     2,948     2,836
    Other                                     44       50        84        93
    Total Segment sales                   $8,919   $7,949   $17,591   $15,880

    Elimination of transfers                 (82)     (74)     (179)     (160)
    Consolidated net sales                $8,837   $7,875   $17,412   $15,720

    (1) Sales for the reporting segments include transfers.



                     E. I. du Pont de Nemours and Company
                       Consolidated Segment Information
                            (Dollars in millions)

    SCHEDULE C (continued)
                                         Three Months Ended  Six Months Ended
                                              June 30,          June 30,

    PRETAX OPERATING INCOME/(LOSS)(PTOI)    2008     2007     2008     2007
    Agriculture & Nutrition                 $504     $428   $1,290   $1,079
    Coatings & Color Technologies            247      226      437      420
    Electronic & Communication
     Technologies                            170      176      345      300
    Performance Materials                    223      227      442      377
    Safety & Protection                      302      318      574      609
    Total Growth Platforms                 1,446    1,375    3,088    2,785

    Pharmaceuticals                          265      241      500      466
    Other                                      1      (37)     (25)     (93)
    Total Segment PTOI                    $1,712   $1,579   $3,563   $3,158

    Net exchange losses (1)                  (29)       8     (184)     (20)
    Corporate expenses & net interest       (271)    (279)    (497)    (518)
    Income before income taxes and
     minority interests                   $1,412   $1,308   $2,882   $2,620


                                         Three Months Ended  Six Months Ended
                                               June 30,          June 30,

    SIGNIFICANT ITEMS BY SEGMENT
     (PRE-TAX) (2)                          2008     2007     2008     2007
    Agriculture & Nutrition                   $-       $-       $-       $-
    Coatings & Color Technologies              -        -        -        -
    Electronic & Communication
     Technologies                              -        -        -        -
    Performance Materials                      -        -        -      (52)
    Safety & Protection                        -        -        -        -
    Other                                      -        -        -        -
    Total Significant Items by segment        $-       $-       $-     $(52)


                                         Three Months Ended  Six Months Ended
                                              June 30,          June 30,

    PTOI EXCLUDING SIGNIFICANT ITEMS        2008     2007     2008     2007
    Agriculture & Nutrition                 $504     $428   $1,290   $1,079
    Coatings & Color Technologies            247      226      437      420
    Electronic & Communication
     Technologies                            170      176      345      300
    Performance Materials                    223      227      442      429
    Safety & Protection                      302      318      574      609
    Total Growth Platforms                 1,446    1,375    3,088    2,837

    Pharmaceuticals                          265      241      500      466
    Other                                      1      (37)     (25)     (93)
    Total Segment PTOI excluding
     Significant Items                    $1,712   $1,579   $3,563   $3,210


    (1) Net after-tax exchange activity for the three months ended June 30,
2008 and 2007 were losses of $37 and $7, respectively. Net after-tax exchange
activity for the six months ended June 30, 2008 and 2007 were losses of $51
and $25, respectively. Gains and losses resulting from the company's hedging
program are largely offset by associated tax effects.  See Schedule D for
additional information.

    (2) Refer to the Notes to Schedules of Significant Items for additional
information.



                     E. I. du Pont de Nemours and Company
                     Reconciliation of Non-GAAP Measures
               (Dollars in millions, except per share amounts)


    SCHEDULE D

    Summary of Earnings Comparisons

                                                  Three Months Ended
                                                        June 30,
                                                                         %
                                                2008          2007    Change

    Segment PTOI                               $1,712        $1,579      8%
    Significant Items charge included in
     PTOI (per Schedule B)                          -             -
    Segment PTOI excluding Significant Items   $1,712        $1,579      8%

    Net Income                                 $1,078          $972     11%
    Significant Items charge included in
     Net Income (per Schedule B)                    -             -
    Net Income excluding Significant Items     $1,078          $972     11%

    EPS                                         $1.18         $1.04     13%
    Significant Items charge included in
     EPS (per Schedule B)                           -           -
    EPS excluding Significant Items             $1.18         $1.04     13%

    Average number of diluted shares
     outstanding                          910,080,000   932,809,000   -2.4%


                                                   Six Months Ended
                                                       June 30
                                                                        %
                                                2008          2007   Change

    Segment PTOI                               $3,563        $3,158     13%
    Significant Items charge included in
     PTOI (per Schedule B)                          -            52
    Segment PTOI excluding Significant Items   $3,563        $3,210     11%

    Net Income                                 $2,269        $1,917     18%
    Significant Items charge included in
     Net Income (per Schedule B)                    -            52
    Net Income excluding Significant Items     $2,269        $1,969     15%

    EPS                                         $2.49         $2.05     21%
    Significant Items charge included in
     EPS (per Schedule B)                           -          0.06
    EPS excluding Significant Items             $2.49         $2.11     18%

    Average number of diluted shares
     outstanding                          908,132,000   933,027,000   -2.7%


    Calculation of Segment PTOI as a
     Percent of Segment Sales

                                                   Three Months Ended
                                                         June 30,
                                                                         %
                                                 2008          2007    Change

    Segment PTOI excluding Significant Items   $1,712        $1,579      8%
    Segment sales                               8,919         7,949     12%

    Segment PTOI as a percent of segment sales  19.2%         19.9%


                                                     Six Months Ended
                                                         June 30,
                                                                         %
                                                 2008          2007    Change

    Segment PTOI excluding Significant Items   $3,563        $3,210     11%
    Segment sales                              17,591        15,880     11%

    Segment PTOI as a percent of segment sales  20.3%         20.2%



                     E. I. du Pont de Nemours and Company
                     Reconciliation of Non-GAAP Measures
               (Dollars in millions, except per share amounts)


    SCHEDULE D (continued)

    Reconciliations of EBIT / EBITDA to Consolidated Income Statement

                                              Three Months      Six Months
                                                 Ended            Ended
                                                June 30,         June 30,
                                              2008    2007    2008     2007

    Income before income taxes and
     minority interests                      $1,412  $1,308   $2,882   $2,620
    Less: Minority interests in (losses)
     earnings of consolidated subsidiaries       (1)      1        5        3
    Add: Interest expense                        94     108      174      207
    EBIT                                      1,507   1,415    3,051    2,824
    Add: Depreciation and amortization          370     343      750      689
    EBITDA                                   $1,877  $1,758   $3,801   $3,513



    Reconciliations of Fixed Costs as a Percent of Sales

                                               Three Months      Six Months
                                                  Ended            Ended
                                                 June 30,         June 30,
                                               2008    2007     2008     2007

    Total charges and expenses
     - consolidated income statements        $7,867  $6,931  $15,167  $13,780
    Remove:
      Interest expense                          (94)   (108)    (174)    (207)
      Variable costs (1)                     (4,542) (3,781)  (8,682)  (7,524)
      Significant Items - charge (2)              -       -        -      (52)
        Fixed costs                          $3,231  $3,042   $6,311   $5,997

    Consolidated net sales                   $8,837  $7,875  $17,412  $15,720

    Fixed costs as a percent of
     consolidated net sales                   36.6%   38.6%    36.2%    38.1%

    (1) Includes variable manufacturing costs, freight, commissions and other
selling expenses which vary with the volume of sales.
    (2) See Schedule B for detail of Significant Items.


    Reconciliation of Earnings Per Share (EPS) Outlook

                                  Six Months Ended          Year Ended
                                     December 31,           December 31,
                                   2008       2007        2008        2007
                                  Outlook    Actual      Outlook     Actual

    Earnings per share -
     excluding Significant
     Items                     $.96 to $1.06  $1.16   $3.45 to $3.55  $3.28
    Significant Items
     included in EPS:
      Impairment charge -
       Performance Materials               -  (0.15)               -  (0.15)
      Litigation related
       charges - Other                     -  (0.03)               -  (0.03)
      Litigation related
       charges, net -
       Performance Materials               -   0.05                -  (0.01)
      Corporate tax-related
       items                               -   0.13                -   0.13
    Net charge for Significant
     Items                                 -      -                -  (0.06)
    Reported EPS               $.96 to $1.06  $1.16   $3.45 to $3.55  $3.22



                     E. I. du Pont de Nemours and Company
                     Reconciliation of Non-GAAP Measures
               (Dollars in millions, except per share amounts)


    SCHEDULE D (continued)

    Exchange Gains/Losses

    The company routinely uses forward exchange contracts to offset its net
exposures, by currency, related to the foreign currency denominated monetary
assets and liabilities of its operations. The objective of this program is to
maintain an approximately balanced position in foreign currencies in order to
minimize, on an after-tax basis, the effects of exchange rate changes.  The
net pretax exchange gains and losses are recorded in Other income, net on the
Consolidated Income Statements and are largely offset by the associated tax
impact.
                                       Three Months Ended  Six Months Ended
                                             June 30,          June 30,
                                           2008     2007     2008     2007
    Subsidiary/Affiliate Monetary
     Position (Gain)/Loss
    Pretax exchange (gains)/losses
     (includes equity affiliates)          $(58)    $(32)   $(209)    $(58)
    Local tax expenses/(benefits)            38       23        4       32
    Net after-tax impact from
     subsidiary exchange (gains)/losses    $(20)     $(9)   $(205)    $(26)

    Hedging Program (Gain)/Loss
    Pretax exchange (gains)/losses          $87      $24     $393      $78
    Tax (benefits)/expenses                 (30)      (8)    (137)     (27)
    Net after-tax impact from hedging
     program exchange (gains)/losses        $57      $16     $256      $51

    Total Exchange (Gain)/Loss
    Pretax exchange (gains)/losses          $29      $(8)    $184      $20
    Tax expenses/(benefits)                   8       15     (133)       5
    Net after-tax exchange
     (gains)/losses                         $37       $7      $51      $25

    As shown above, the "Total Exchange (Gain)/Loss" is the sum of the
"Subsidiary/Affiliate Monetary Position (Gain)/Loss" and the "Hedging Program
(Gain)/Loss."
    Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
    Base income tax rate is defined as the effective income tax rate less the
effect of exchange gains/losses, as defined above, and significant items.
                                       Three Months Ended  Six Months Ended
                                             June 30,           June 30,
                                           2008     2007     2008     2007

    Income before income taxes and
     minority interests                  $1,412   $1,308   $2,882   $2,620
    Add:  Significant Items - charge          -        -        -       52
          Net exchange losses                29       (8)     184       20
    Income before income taxes,
     Significant Items, exchange
     gains/losses and minority
     interests                           $1,441   $1,300   $3,066   $2,692

    Provision for income taxes             $335     $335     $608     $700
    Add: Tax benefit on Significant Items     -        -        -        -
         Tax benefit on exchange
          gains/losses                       (8)     (15)     133       (5)
    Provision for income taxes,
     excluding taxes on Significant
     Items and exchange gains/losses       $327     $320     $741     $695

    Effective income tax rate              23.7%    25.6%    21.1%    26.7%
    Significant Items effect                0.0%     0.0%     0.0%    (0.5)%
    Tax rate before significant items      23.7%    25.6%    21.1%    26.2%
    Exchange gains/losses effect           (1.0)%   (1.0)%    3.1%    (0.4)%
    Base income tax rate                   22.7%    24.6%    24.2%    25.8%


SOURCE  DuPont

Anthony Farina of DuPont, +1-302-774-4005, anthony.r.farina@usa.dupont.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.